Anti-lipopolysaccharide antibody levels in patients with AIDS at the onset of Pseudomonas aeruginosa bacteremia.
Lipopolysaccharide (LPS) in the cell wall of the P. aeruginosa is a major factor in the pathogenicity and virulence of this organism. Immunotype-specific serum antibodies to this LPS antigen (ALPS) are usually elevated with the onset of the bacteremia, act as opsonins, are protective in high levels, and are significantly associated with improved survival. In the present study, the ability of 11 patients with AIDS to mount a specific ALPS response with the onset of P. aeruginosa bacteria was evaluated prospectively. Of the 11 patients with AIDS only one had a substantial ALPS response, six mounted only a marginal ALPS response, and four had no ALPS response to the infecting strain of the P. aeruginosa. These data suggest most patients with AIDS do not exhibit a marked antigen-specific humoral response at the onset of P. aeruginosa bacteremia; this has important prognostic and therapeutic significance, as high ALPS titers are associated with survival.
Kumar
P N
PN
Division of Infectious Diseases, Georgetown University Hospital, Washington, D.C.
Collins
M S
MS
Pierce
P F
PF
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology* / Q000401:mortality; D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood; D016470:Bacteremia / Q000150:complications / Q000276:immunology*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008070:Lipopolysaccharides / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009895:Opsonin Proteins / Q000276:immunology; D011379:Prognosis; D011446:Prospective Studies; D011552:Pseudomonas Infections / Q000150:complications / Q000276:immunology* / Q000401:mortality; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D012307:Risk Factors; D015996:Survival Rate
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D009895:Opsonin Proteins